Sanofi and Regeneron Pharmaceuticals will collaborate on four next-generation antibody drugs that could offer advantages over Dupixent, the blockbuster immunology drug spawned by their R&D alliance. The companies project these drugs will start reaching pivotal testing in 2029 — important because Dupixent faces patent expiration in 2031. The post Sanofi Puts Up $1B to Expand Regeneron Alliance and Develop Next-Gen Dupixent appeared first on MedCity News.

Why more than 300,000 missing patient records reveal an engineering problem, not a policy one — and why that’s good news. The post The Real Gap in All of Us Isn’t Consent, It’s Conversion appeared first on MedCity News.

The FDA is recruiting to fill vacancies on its advisory committees, informally known as adcomms. While these committees have met less frequently during the Trump administration, more meetings have been scheduled since former Commissioner Marty Makary left the agency in May. The post FDA Looks to Bring New Scientific, Consumer Voices to Advisory Committees appeared first on MedCity News.

In this episode, we’re joined by Claire Love, PwC’s global health industries advisory leader. We discuss PwC’s recent report showing the opportunities in the fertility and reproductive health market. The post MedCity FemFwd: Opportunities in the Fertility Market appeared first on MedCity News.

Health tech companies made several major funding announcements in September. Here is a list of some of the biggest funding rounds. The post 4 Notable Health Tech Funding Announcements in September appeared first on MedCity News.

For one ICU physician and startup CMO, the more immediate danger isn’t an autonomous system taking over medicine and leaving human decision-making behind. It’s healthcare organizations harnessing AI primarily to increase efficiency while leaving healthcare providers even more mired in complexity and regulation. The post AI’s Healthcare ‘Doomsday’? It May Be Less About Autonomy Than Trust appeared first on MedCity News.

AI could play a meaningful role in advancing social care. Not by replacing people, but by helping them and organizations doing this work move faster, see patterns earlier, and coordinate more effectively.  The post AI Won’t Fix Social Care, But Could It Help Us Finally Make It Work? appeared first on MedCity News.

Tiny Health’s Series B round was led by B Capital, with participation from Spero Ventures, The Venture City, Overwater Ventures, Black Opal Ventures, Denver Ventures, Pave Health Ventures, Alumni Ventures, Gaingels and Pari Passu Ventures. The post Tiny Health Secures $33M to Expand Microbiome Testing appeared first on MedCity News.

Unite Us and Instacart announced Tuesday that they are partnering to connect healthcare organizations’ care coordination efforts with grocery benefits, with the aim of making food-as-medicine programs easier to launch and operate at scale. The post Unite Us, Instacart Link Care Coordination and Grocery Benefits to Scale Food-as-Medicine appeared first on MedCity News.

AstraZeneca’s equity investment in Summit Therapeutics comes with plans for clinical trial collaborations. The deal brings AstraZeneca into a growing group of pharmaceutical companies testing the pairing of antibody drug conjugates with PD-1/VEGF bispecific antibodies, a drug combination that could offer advantages in cancer treatment. The post AstraZeneca Places a $2B Bet on a Summit Therapeutics Cancer Drug appeared first on MedCity News.

In this episode of the MedCity Pivot Podcast, CEO Priya Abani talks about the evolution of AliveCor, one of the earliest digital health companies. The post MedCity Pivot Podcast: A Conversation With AliveCor’s Priya Abani appeared first on MedCity News.

Patients obtaining drugs through social media, medical spas, or telehealth platforms are not the same as patients obtaining drugs through more traditional illicit channels because they often believe what they are receiving is a clinically validated product. This means they may present with unexplained symptoms without realizing their online purchase is even relevant to the conversation The post The Illegal Drug Marketplace in Your Patients’ Pockets appeared first on MedCity News.

DreaMed Diabetes has received FDA 510(K) clearance for MODI, a mobile app that uses CGM (continuous glucose monitoring) data to provide insulin dosing recommendations for people with Type 2 diabetes who need both basal insulin and fast-acting injections. The post DreaMed Wins FDA Clearance for CGM-Driven Insulin Automation Tool for Both Type 2 Injection Regimens appeared first on MedCity News.

The Association for Direct Care launched a coalition focused on expanding direct contracting to lower healthcare costs. The post New Coalition Launches to Expand Direct Contracting appeared first on MedCity News.

Merck now has global rights to a SciBrunch Therapeutics drug candidate designed to block mutated versions of the cancer-driving protein KRAS G12D. This class of targeted cancer therapies includes clinical-stage assets from Revolution Medicines, BridgeBio Oncology Therapeutics, and Verastem Oncology. The post Merck Pays $400M for Cancer Drug Prospect From China-Based SciBrunch appeared first on MedCity News.